Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for primary liver cancer. To learn more about a study, choose from the list below.
Title |
Investigator |
|---|---|
|
A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma [Protocol 10-021] |
Abou-Alfa, Ghassan, MD |
|
A Phase III Study of ADI-PEG20/Supportive Care or Placebo/Supportive Care in Patients with Advanced Liver Cancer [Protocol 11-081] |
Abou-Alfa, Ghassan, MD |
|
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma [Protocol 07-099] |
Brown, Karen, MD |
|
Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer [Protocol 11-039] |
Abou-Alfa, Ghassan, MD |
|
Treatment of Children with All Stages of Hepatoblastoma [Protocol 10-046] |
Kobos, Rachel, MD |
